NEWS RELEASE – REGULATED INFORMATION
INSIDE INFORMATION
28 OCTOBER 2021, 07:00 CEST
MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs
in the United States
IRVINE, CA, and HERSTAL, BELGIUM – October 28, 2021 – MDxHealth SA (Euronext Brussels: MDXH) (“MDxHealth” or the “Company“), a commercial-stage precision diagnostics company, today announced that it is launching a registered initial public offering (the “Offering”) of 3,750,000 American Depositary Shares (each representing 10 ordinary shares of the Company with no nominal value per share) (“ADSs“).
In connection with the Offering, MDxHealth intends to grant the underwriters a 30-day option to purchase additional ordinary shares, which may be in the form of ADSs, in an aggregate amount of up to 15% of the total number of ordinary shares (as the case may be, in the form of ADSs) offered in the Offering on the same terms and conditions.
The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering, including the price per ADS and number of ADSs sold in the Offering.
MDxHealth’s ordinary shares are currently listed on Euronext Brussels under the symbol “MDXH”. An application has been made to list the ADSs on the Nasdaq Capital Market under the same symbol.
Piper Sandler and Oppenheimer & Co. Inc. are acting as lead book-running managers, BTIG is acting as a…
